Silgan (SLGN) Financials

Silgan logo
$40.69 -0.21 (-0.51%)
Closing price 03:59 PM Eastern
Extended Trading
$40.72 +0.03 (+0.07%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Silgan

Annual Income Statements for Silgan

This table shows Silgan's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
172 153 270 224 194 309 359 341 326 276 288
Consolidated Net Income / (Loss)
172 153 270 224 194 309 359 341 326 276 288
Net Income / (Loss) Continuing Operations
172 153 270 224 194 309 359 341 326 276 288
Total Pre-Tax Income
253 232 240 293 252 407 466 474 422 348 409
Total Operating Income
320 300 357 412 359 512 576 602 595 515 598
Total Gross Profit
554 512 635 690 714 867 918 1,048 993 1,012 1,149
Total Revenue
3,764 3,613 4,090 4,449 4,490 4,922 5,677 6,411 5,988 5,855 6,483
Operating Revenue
3,764 3,613 4,090 4,449 4,490 4,922 5,677 6,411 5,988 5,855 6,483
Total Cost of Revenue
3,210 3,101 3,455 3,759 3,776 4,055 4,759 5,364 4,996 4,843 5,334
Operating Cost of Revenue
3,210 3,101 3,455 3,759 3,776 4,055 4,759 5,364 4,996 4,843 5,334
Total Operating Expenses
234 212 278 278 354 355 342 446 397 497 552
Selling, General & Admin Expense
220 220 305 308 316 378 378 417 384 438 493
Restructuring Charge
14 19 5.83 6.25 56 16 15 74 8.41 59 61
Other Special Charges / (Income)
- -27 -33 -37 -18 -39 -51 -45 4.33 -1.19 -1.62
Total Other Income / (Expense), net
-67 -68 -117 -119 -107 -105 -110 -128 -173 -167 -189
Interest Expense
67 68 117 119 107 105 110 128 173 167 189
Income Tax Expense
80 79 -30 69 58 98 107 133 96 72 123
Other Gains / (Losses), net
- - - - - - - 0.00 0.00 0.69 3.16
Basic Earnings per Share
$1.41 $1.28 $2.44 $2.03 $1.75 $2.79 $3.25 $3.09 $3.00 $2.59 $2.71
Weighted Average Basic Shares Outstanding
61.02M 119.73M 110.35M 110.60M 110.78M 110.06M 110.41M 110.08M 106.50M 106.79M 105.44M
Diluted Earnings per Share
$1.41 $1.27 $2.42 $2.01 $1.74 $2.77 $3.23 $3.07 $2.98 $2.58 $2.70
Weighted Average Diluted Shares Outstanding
61.02M 119.73M 110.35M 110.60M 110.78M 110.06M 110.41M 110.08M 106.50M 106.79M 105.44M
Weighted Average Basic & Diluted Shares Outstanding
61.02M 119.73M 110.35M 110.60M 110.78M 110.06M 110.41M 110.08M 106.50M 106.79M 105.44M
Cash Dividends to Common per Share
$0.32 $0.68 $0.36 $0.40 $0.44 $0.48 $0.56 $0.64 $0.72 $0.76 $0.80

Quarterly Income Statements for Silgan

This table shows Silgan's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Income / (Loss) Attributable to Common Shareholders
55 76 100 45 68 89 113 18 63 76 105
Consolidated Net Income / (Loss)
55 76 100 45 68 89 113 18 63 76 105
Net Income / (Loss) Continuing Operations
55 76 100 45 68 89 113 18 63 76 105
Total Pre-Tax Income
73 101 125 49 88 119 149 53 84 104 144
Total Operating Income
112 142 167 94 131 168 199 101 127 151 192
Total Gross Profit
223 256 293 239 270 299 327 253 266 295 329
Total Revenue
1,317 1,381 1,745 1,411 1,467 1,539 2,009 1,469 1,561 1,643 2,040
Operating Revenue
1,317 1,381 1,745 1,411 1,467 1,539 2,009 1,469 1,561 1,643 2,040
Total Cost of Revenue
1,094 1,125 1,452 1,172 1,196 1,240 1,681 1,216 1,295 1,348 1,712
Operating Cost of Revenue
1,094 1,125 1,452 1,172 1,196 1,240 1,681 1,216 1,295 1,348 1,712
Total Operating Expenses
112 114 126 145 140 132 129 152 139 144 137
Selling, General & Admin Expense
100 108 106 124 129 122 122 120 131 127 121
Restructuring Charge
12 6.86 19 21 11 9.86 7.19 32 9.05 18 17
Other Special Charges / (Income)
-0.41 -0.41 0.12 -0.49 -0.19 -0.14 -0.81 -0.49 -1.04 -1.11 -1.00
Total Other Income / (Expense), net
-39 -41 -42 -46 -43 -49 -50 -48 -42 -47 -47
Interest Expense
39 41 42 46 43 49 50 48 42 47 47
Income Tax Expense
18 24 25 4.29 21 30 36 36 22 29 40
Other Gains / (Losses), net
0.00 0.00 0.00 - 1.16 0.56 0.78 0.67 1.20 0.98 0.84
Basic Earnings per Share
$0.52 $0.71 $0.94 $0.42 $0.64 $0.83 $1.06 $0.18 $0.60 $0.72 $0.99
Weighted Average Basic Shares Outstanding
106.65M 106.84M 106.85M 106.79M 106.92M 106.99M 105.67M 105.44M 105.59M 105.68M 105.68M
Diluted Earnings per Share
$0.52 $0.71 $0.93 $0.42 $0.63 $0.83 $1.06 $0.18 $0.60 $0.72 $0.99
Weighted Average Diluted Shares Outstanding
107.05M 107.02M 107.14M 106.79M 107.34M 106.99M 105.67M 105.44M 105.86M 105.68M 105.68M
Weighted Average Basic & Diluted Shares Outstanding
106.78M 106.78M 106.79M 106.79M 106.99M 106.99M 105.67M 105.44M 105.68M 105.68M 105.68M

Annual Cash Flow Statements for Silgan

This table details how cash moves in and out of Silgan's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-123 -75 29 19 131 206 222 -46 57 180 258
Net Cash From Operating Activities
336 395 390 507 507 603 557 748 483 722 730
Net Cash From Continuing Operating Activities
336 395 390 507 507 603 557 748 483 722 730
Net Income / (Loss) Continuing Operations
172 153 270 224 194 309 359 341 326 276 288
Consolidated Net Income / (Loss)
172 153 270 224 194 309 359 341 326 276 288
Depreciation Expense
142 143 174 192 206 219 250 263 263 276 319
Amortization Expense
4.16 4.14 4.26 3.77 3.46 4.54 5.57 5.46 5.37 5.47 5.53
Non-Cash Adjustments To Reconcile Net Income
26 32 28 24 75 36 97 92 24 76 79
Changes in Operating Assets and Liabilities, net
-9.48 62 -86 63 28 34 -155 47 -136 88 38
Net Cash From Investing Activities
-237 -180 -1,198 -190 -230 -1,163 -976 -216 -224 -1,176 -297
Net Cash From Continuing Investing Activities
-237 -180 -1,198 -190 -230 -1,163 -976 -216 -224 -1,176 -297
Purchase of Property, Plant & Equipment
-237 -192 -174 -191 -231 -224 -232 -216 -227 -263 -307
Acquisitions
-0.69 0.00 -1,024 0.00 0.00 -941 -746 -2.50 0.00 -922 0.00
Sale of Property, Plant & Equipment
0.90 - - - - - 2.80 3.35 1.76 7.80 10
Other Investing Activities, net
- 12 0.60 1.05 0.85 1.87 -0.82 -0.69 1.24 0.26 -0.25
Net Cash From Financing Activities
-221 -289 837 -294 -146 760 649 -570 -211 663 -207
Net Cash From Continuing Financing Activities
-221 -289 837 -294 -146 760 649 -570 -211 663 -207
Repayment of Debt
-767 -865 -2,089 -1,280 -462 -1,831 -2,106 -1,120 -60 -1,147 -763
Repurchase of Common Equity
-173 -281 -4.12 -7.83 -28 -42 -8.57 -45 -184 -9.32 -75
Payment of Dividends
-40 -41 -40 -45 -51 -54 -62 -72 -79 -82 -86
Issuance of Debt
740 919 2,961 1,043 400 2,681 2,685 835 12 1,977 704
Other Financing Activities, net
19 -23 8.85 -4.13 -4.66 5.20 140 -167 99 -76 12
Effect of Exchange Rate Changes
- 0.00 0.00 -3.70 -0.74 6.47 -7.53 -9.03 9.91 -28 33
Cash Interest Paid
64 65 98 118 109 90 102 124 155 160 185
Cash Income Taxes Paid
50 58 70 47 41 121 94 94 116 92 104

Quarterly Cash Flow Statements for Silgan

This table details how cash moves in and out of Silgan's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
-334 -5.85 66 454 -470 -36 72 691 -645 -84 -27
Net Cash From Operating Activities
-548 21 313 936 -683 -221 341 1,294 -800 -194 347
Net Cash From Continuing Operating Activities
-548 21 313 936 -683 -221 341 1,294 -800 -194 347
Net Income / (Loss) Continuing Operations
55 76 100 45 68 89 113 18 63 76 105
Consolidated Net Income / (Loss)
55 76 100 45 68 89 113 18 63 76 105
Depreciation Expense
66 66 67 77 79 76 83 81 85 84 84
Amortization Expense
1.35 1.35 1.35 1.43 1.41 1.20 1.29 1.62 1.63 1.40 1.40
Non-Cash Adjustments To Reconcile Net Income
16 11 23 26 15 13 12 38 16 25 22
Changes in Operating Assets and Liabilities, net
-687 -133 122 786 -847 -401 131 1,155 -965 -380 136
Net Cash From Investing Activities
-72 -56 -61 -987 -82 -63 -81 -70 -80 -62 -82
Net Cash From Continuing Investing Activities
-72 -56 -61 -987 -82 -63 -81 -70 -80 -62 -82
Purchase of Property, Plant & Equipment
-75 -56 -61 -71 -83 -73 -80 -71 -82 -64 -83
Sale of Property, Plant & Equipment
2.50 0.49 0.24 4.58 0.05 9.50 0.20 0.28 2.07 2.29 0.37
Other Investing Activities, net
0.30 -0.25 -0.34 0.55 0.40 -0.10 -1.59 1.04 0.40 0.24 -0.10
Net Cash From Financing Activities
293 36 -195 528 283 231 -188 -533 234 172 -290
Net Cash From Continuing Financing Activities
293 36 -195 528 283 231 -188 -533 234 172 -290
Repayment of Debt
-115 -60 -235 -709 -712 -46 -892 888 -706 -20 -280
Payment of Dividends
-21 -20 -20 -20 -22 -21 -21 -21 -23 -22 -22
Issuance of Debt
598 142 63 1,174 1,111 299 786 -1,492 1,069 215 13
Other Financing Activities, net
-161 -25 -2.01 85 -86 -1.08 -1.54 101 -99 -0.77 -1.01
Effect of Exchange Rate Changes
-6.69 - - -23 13 18 0.77 0.56 0.53 0.15 -1.30
Cash Interest Paid
50 41 43 27 51 53 45 37 52 40 44
Cash Income Taxes Paid
17 27 26 22 12 33 17 42 7.88 43 60

Annual Balance Sheets for Silgan

This table presents Silgan's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
3,193 3,149 4,645 4,579 4,931 6,512 7,771 7,346 7,611 8,585 9,397
Total Current Assets
1,045 962 1,292 1,290 1,407 1,799 2,296 2,133 2,349 2,523 2,992
Cash & Equivalents
100 25 54 73 204 409 631 586 643 823 1,081
Accounts Receivable
281 288 455 511 505 620 711 658 600 594 589
Inventories, net
628 603 721 635 633 678 799 769 941 928 1,080
Prepaid Expenses
36 46 62 71 65 93 154 120 166 177 242
Plant, Property, & Equipment, net
1,125 1,157 1,490 1,518 0.00 0.00 1,994 1,931 1,962 2,283 2,378
Total Noncurrent Assets
1,022 1,030 1,864 1,772 3,524 4,712 3,481 3,282 3,301 3,779 4,027
Goodwill
613 605 1,171 1,148 1,142 1,741 2,038 1,985 2,018 2,316 2,487
Intangible Assets
195 181 417 383 355 637 831 764 721 869 900
Other Noncurrent Operating Assets
214 245 275 240 2,027 2,334 612 533 561 594 640
Total Liabilities & Shareholders' Equity
3,193 3,149 4,645 4,579 4,931 6,512 7,771 7,346 7,611 8,585 9,397
Total Liabilities
2,553 2,680 3,879 3,698 3,908 5,259 6,208 5,628 5,722 6,595 7,123
Total Current Liabilities
781 862 958 1,079 1,019 1,192 1,509 1,438 2,312 2,248 2,452
Short-Term Debt
152 217 109 170 30 28 20 80 880 717 632
Accounts Payable
477 505 660 713 727 803 1,133 974 1,076 1,112 1,252
Accrued Expenses
107 94 124 127 195 231 246 285 258 310 447
Current Employee Benefit Liabilities
45 46 66 69 67 130 109 99 98 109 121
Total Noncurrent Liabilities
1,772 1,818 2,921 2,619 2,889 4,067 4,700 4,190 3,410 4,348 4,671
Long-Term Debt
1,361 1,344 2,439 2,134 2,215 3,223 3,773 3,345 2,546 3,420 3,715
Noncurrent Deferred & Payable Income Tax Liabilities
- 298 262 268 255 356 435 389 434 506 502
Other Noncurrent Operating Liabilities
411 175 220 217 420 488 491 456 430 422 454
Total Equity & Noncontrolling Interests
639 469 766 881 1,023 1,253 1,563 1,718 1,889 1,990 2,274
Total Preferred & Common Equity
639 469 766 881 1,023 1,253 1,563 1,718 1,889 1,990 2,274
Total Common Equity
639 469 766 881 1,023 1,253 1,563 1,718 1,889 1,990 2,274
Common Stock
238 251 264 278 291 308 327 342 356 370 387
Retained Earnings
1,446 1,559 1,810 1,998 2,141 2,395 2,692 2,961 3,208 3,403 3,605
Accumulated Other Comprehensive Income / (Loss)
-209 -224 -189 -269 -260 -261 -260 -345 -251 -353 -214
Other Equity Adjustments
- - - - - - - - -1,423 - -1,504

Quarterly Balance Sheets for Silgan

This table presents Silgan's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
7,914 7,812 7,574 7,693 7,747 8,768 9,410 9,498 9,322 9,601 9,396
Total Current Assets
2,698 2,662 2,376 2,539 2,519 2,597 3,009 3,112 2,967 3,294 3,099
Cash & Equivalents
237 307 309 303 369 353 317 389 435 352 325
Accounts Receivable
1,068 1,296 946 1,057 1,210 1,013 1,242 1,503 1,159 1,455 1,628
Inventories, net
1,252 919 957 1,006 780 1,055 1,259 1,022 1,129 1,232 917
Prepaid Expenses
143 140 164 173 160 176 191 198 244 256 230
Plant, Property, & Equipment, net
1,934 1,912 1,944 1,934 1,956 2,303 2,382 2,393 2,355 2,335 2,331
Total Noncurrent Assets
3,281 3,239 3,254 3,221 3,272 3,868 4,019 3,993 4,000 3,972 3,966
Goodwill
2,007 1,980 1,997 1,987 2,024 2,373 2,485 2,481 2,465 2,457 2,448
Intangible Assets
745 724 702 685 681 890 907 892 879 861 843
Other Noncurrent Operating Assets
528 535 555 549 566 605 628 620 657 655 675
Total Liabilities & Shareholders' Equity
7,914 7,812 7,574 7,693 7,747 8,768 9,410 9,498 9,322 9,601 9,396
Total Liabilities
6,043 6,030 5,674 5,760 5,693 6,685 7,188 7,226 7,002 7,221 6,918
Total Current Liabilities
1,880 1,916 2,289 2,396 2,306 2,285 3,135 2,451 2,358 2,590 2,288
Short-Term Debt
811 898 1,346 1,398 1,254 1,145 1,937 1,135 988 1,178 908
Accounts Payable
752 652 610 658 679 737 757 852 817 892 884
Accrued Expenses
222 269 234 239 266 284 317 335 432 395 376
Current Employee Benefit Liabilities
95 96 100 101 106 119 122 129 121 125 121
Total Noncurrent Liabilities
4,163 4,115 3,385 3,364 3,388 4,399 4,054 4,775 4,644 4,631 4,630
Long-Term Debt
3,351 3,313 2,535 2,531 2,554 3,483 3,115 3,812 3,672 3,656 3,640
Noncurrent Deferred & Payable Income Tax Liabilities
384 380 432 425 421 487 479 511 516 521 534
Other Noncurrent Operating Liabilities
427 422 418 408 413 429 460 452 456 455 455
Total Equity & Noncontrolling Interests
1,871 1,782 1,900 1,934 2,054 2,083 2,222 2,272 2,321 2,379 2,478
Total Preferred & Common Equity
1,871 1,782 1,900 1,934 2,054 2,083 2,222 2,272 2,321 2,379 2,478
Total Common Equity
1,871 1,782 1,900 1,934 2,054 2,083 2,222 2,272 2,321 2,379 2,478
Common Stock
347 351 358 362 366 373 376 381 391 398 402
Retained Earnings
3,072 3,163 3,243 3,299 3,378 3,449 3,516 3,608 3,646 3,699 3,781
Accumulated Other Comprehensive Income / (Loss)
-280 -310 -272 -298 -261 -303 -235 -222 -206 -207 -195
Other Equity Adjustments
-1,269 -1,423 -1,429 -1,429 -1,429 -1,435 -1,435 - -1,510 -1,510 -1,510

Annual Metrics And Ratios for Silgan

This table displays calculated financial ratios and metrics derived from Silgan's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-3.78% -4.01% 13.20% 8.78% 0.92% 9.62% 15.34% 12.94% -6.60% -2.23% 10.73%
EBITDA Growth
-9.16% -4.13% 19.78% 13.51% -6.28% 29.26% 13.04% 4.59% -0.71% -7.82% 15.83%
EBIT Growth
-11.37% -6.28% 19.10% 15.44% -12.77% 42.53% 12.44% 4.49% -1.08% -13.49% 16.07%
NOPAT Growth
-5.73% -9.10% 102.65% -21.64% -12.20% 40.62% 14.17% -2.46% 6.25% -11.17% 2.21%
Net Income Growth
-5.47% -11.06% 75.84% -16.93% -13.47% 59.29% 16.31% -5.08% -4.37% -15.21% 4.35%
EPS Growth
-50.70% -9.93% 90.55% -16.94% -13.43% 59.20% 16.61% -4.95% -2.93% -13.42% 4.65%
Operating Cash Flow Growth
-3.58% 17.51% -1.21% 29.96% 0.16% 18.75% -7.58% 34.40% -35.52% 49.58% 1.10%
Free Cash Flow Firm Growth
-43.25% 3.37% -448.17% 154.17% -29.47% -297.29% 71.01% 421.82% -42.47% -164.39% 181.36%
Invested Capital Growth
-0.90% -2.26% 62.48% -4.50% -1.58% 33.64% 15.38% -3.52% 2.53% 13.49% 4.47%
Revenue Q/Q Growth
-2.10% -0.65% 4.87% 1.71% -0.49% 3.76% 3.89% 0.25% -1.89% 1.23% 0.89%
EBITDA Q/Q Growth
-0.83% 0.95% 10.31% -0.68% 0.31% 6.36% 4.79% -4.98% 6.93% -2.58% 1.19%
EBIT Q/Q Growth
-2.02% -0.10% 10.60% -2.16% -1.61% 7.00% 4.29% -7.32% 8.17% -5.83% 1.17%
NOPAT Q/Q Growth
1.73% -1.55% 84.55% -32.45% -2.67% 7.90% 6.92% -12.46% 12.41% -3.39% -8.60%
Net Income Q/Q Growth
1.72% -1.83% 83.15% -32.52% -1.70% 8.91% 7.46% -15.06% 13.92% -6.55% -8.52%
EPS Q/Q Growth
-48.91% 323.33% 120.00% -32.55% -1.69% 9.06% 7.31% -14.72% 14.18% -6.52% -8.16%
Operating Cash Flow Q/Q Growth
-4.96% 6.15% -2.96% 24.36% 3.33% -4.09% 16.43% 68.15% 78.81% -16.52% 96.30%
Free Cash Flow Firm Q/Q Growth
-36.06% 42.77% -1.91% 37.43% -26.30% -5.23% 56.11% 15.50% 2,913.15% -136.11% 120.51%
Invested Capital Q/Q Growth
-16.10% -18.99% -7.66% -14.95% -12.52% -8.46% -11.06% -13.80% -17.80% -3.46% -18.89%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
14.72% 14.17% 15.52% 15.50% 15.90% 17.62% 16.18% 16.34% 16.58% 17.28% 17.73%
EBITDA Margin
12.38% 12.37% 13.09% 13.66% 12.68% 14.95% 14.66% 13.57% 14.43% 13.60% 14.23%
Operating Margin
8.50% 8.30% 8.73% 9.26% 8.01% 10.41% 10.15% 9.39% 9.94% 8.80% 9.22%
EBIT Margin
8.50% 8.30% 8.73% 9.26% 8.01% 10.41% 10.15% 9.39% 9.94% 8.80% 9.22%
Profit (Net Income) Margin
4.58% 4.24% 6.59% 5.03% 4.32% 6.27% 6.33% 5.32% 5.44% 4.72% 4.45%
Tax Burden Percent
68.18% 66.12% 112.51% 76.37% 76.87% 75.84% 77.00% 71.89% 77.22% 79.49% 70.60%
Interest Burden Percent
79.07% 77.38% 67.14% 71.17% 70.14% 79.45% 80.94% 78.77% 70.89% 67.50% 68.33%
Effective Tax Rate
31.82% 33.88% -12.51% 23.63% 23.13% 24.16% 23.00% 28.11% 22.78% 20.70% 30.17%
Return on Invested Capital (ROIC)
10.57% 9.77% 15.25% 9.88% 8.95% 10.86% 10.06% 9.32% 9.96% 8.19% 7.70%
ROIC Less NNEP Spread (ROIC-NNEP)
7.29% 6.73% 8.70% 6.04% 5.08% 7.59% 7.24% 6.26% 5.20% 3.86% 3.78%
Return on Net Nonoperating Assets (RNNOA)
14.99% 17.90% 28.40% 17.32% 11.41% 16.27% 15.45% 11.45% 8.11% 6.06% 5.83%
Return on Equity (ROE)
25.56% 27.67% 43.65% 27.19% 20.35% 27.13% 25.51% 20.78% 18.07% 14.25% 13.53%
Cash Return on Invested Capital (CROIC)
11.48% 12.06% -32.35% 14.48% 10.54% -17.94% -4.22% 12.91% 7.47% -4.45% 3.33%
Operating Return on Assets (OROA)
9.89% 9.45% 9.16% 8.93% 7.56% 8.96% 8.07% 7.96% 7.96% 6.36% 6.65%
Return on Assets (ROA)
5.33% 4.84% 6.92% 4.86% 4.08% 5.40% 5.03% 4.51% 4.36% 3.41% 3.21%
Return on Common Equity (ROCE)
25.56% 27.67% 43.65% 27.19% 20.35% 27.13% 25.51% 20.78% 18.07% 14.25% 13.53%
Return on Equity Simple (ROE_SIMPLE)
26.97% 32.67% 35.20% 25.42% 18.94% 24.64% 22.98% 19.84% 17.25% 13.89% 0.00%
Net Operating Profit after Tax (NOPAT)
218 198 402 315 276 389 444 433 460 408 417
NOPAT Margin
5.79% 5.49% 9.82% 7.07% 6.15% 7.90% 7.81% 6.75% 7.68% 6.98% 6.44%
Net Nonoperating Expense Percent (NNEP)
3.29% 3.04% 6.55% 3.84% 3.86% 3.27% 2.82% 3.06% 4.76% 4.33% 3.92%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 8.41% 8.65% 6.67% 6.31%
Cost of Revenue to Revenue
85.28% 85.83% 84.48% 84.50% 84.10% 82.38% 83.82% 83.66% 83.42% 82.72% 82.27%
SG&A Expenses to Revenue
5.84% 6.09% 7.46% 6.93% 7.03% 7.67% 6.66% 6.50% 6.42% 7.49% 7.60%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
6.23% 5.87% 6.79% 6.24% 7.89% 7.21% 6.03% 6.95% 6.63% 8.48% 8.51%
Earnings before Interest and Taxes (EBIT)
320 300 357 412 359 512 576 602 595 515 598
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
466 447 535 608 569 736 832 870 864 796 923
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.25 2.96 3.85 2.74 3.15 3.11 2.91 3.22 2.51 2.79 1.88
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.38 0.38 0.72 0.54 0.72 0.79 0.80 0.86 0.79 0.95 0.66
Price to Earnings (P/E)
8.35 9.06 10.94 10.76 16.64 12.62 12.68 16.23 14.56 20.11 14.79
Dividend Yield
2.68% 2.95% 1.68% 1.84% 1.51% 1.36% 1.36% 1.27% 1.62% 1.46% 1.98%
Earnings Yield
11.98% 11.04% 9.14% 9.29% 6.01% 7.92% 7.88% 6.16% 6.87% 4.97% 6.76%
Enterprise Value to Invested Capital (EV/IC)
1.39 1.46 1.67 1.49 1.72 1.65 1.63 1.84 1.61 1.67 1.36
Enterprise Value to Revenue (EV/Rev)
0.76 0.81 1.33 1.04 1.17 1.37 1.36 1.31 1.26 1.52 1.16
Enterprise Value to EBITDA (EV/EBITDA)
6.12 6.55 10.17 7.64 9.25 9.16 9.27 9.62 8.71 11.14 8.16
Enterprise Value to EBIT (EV/EBIT)
8.92 9.76 15.25 11.27 14.65 13.15 13.39 13.91 12.65 17.23 12.60
Enterprise Value to NOPAT (EV/NOPAT)
13.09 14.76 13.55 14.75 19.05 17.34 17.39 19.35 16.38 21.72 18.04
Enterprise Value to Operating Cash Flow (EV/OCF)
8.50 7.42 13.97 9.17 10.38 11.18 13.86 11.19 15.60 12.29 10.32
Enterprise Value to Free Cash Flow (EV/FCFF)
12.06 11.96 0.00 10.06 16.18 0.00 0.00 13.97 21.85 0.00 41.71
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
2.37 3.33 3.33 2.62 2.19 2.60 2.43 1.99 1.81 2.08 1.91
Long-Term Debt to Equity
2.13 2.86 3.18 2.42 2.16 2.57 2.41 1.95 1.35 1.72 1.63
Financial Leverage
2.06 2.66 3.26 2.87 2.24 2.15 2.13 1.83 1.56 1.57 1.54
Leverage Ratio
4.79 5.72 6.31 5.60 4.99 5.03 5.07 4.61 4.15 4.18 4.22
Compound Leverage Factor
3.79 4.43 4.24 3.99 3.50 3.99 4.11 3.63 2.94 2.82 2.88
Debt to Total Capital
70.31% 76.89% 76.88% 72.34% 68.68% 72.18% 70.82% 66.59% 64.46% 67.52% 65.65%
Short-Term Debt to Total Capital
7.08% 10.69% 3.28% 5.34% 0.91% 0.62% 0.38% 1.56% 16.56% 11.70% 9.54%
Long-Term Debt to Total Capital
63.23% 66.20% 73.60% 67.00% 67.77% 71.56% 70.44% 65.04% 47.90% 55.82% 56.11%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
29.69% 23.11% 23.12% 27.66% 31.32% 27.82% 29.18% 33.41% 35.54% 32.48% 34.35%
Debt to EBITDA
3.25 3.49 4.76 3.79 3.94 4.42 4.56 3.94 3.97 5.19 4.71
Net Debt to EBITDA
3.03 3.44 4.66 3.67 3.58 3.86 3.80 3.26 3.22 4.16 3.54
Long-Term Debt to EBITDA
2.92 3.01 4.56 3.51 3.89 4.38 4.53 3.84 2.95 4.29 4.03
Debt to NOPAT
6.94 7.88 6.34 7.32 8.12 8.37 8.55 7.92 7.45 10.13 10.41
Net Debt to NOPAT
6.48 7.75 6.21 7.09 7.38 7.31 7.13 6.56 6.05 8.11 7.82
Long-Term Debt to NOPAT
6.24 6.78 6.07 6.78 8.01 8.29 8.50 7.73 5.54 8.37 8.90
Altman Z-Score
2.58 2.50 2.22 2.33 2.35 2.09 2.02 2.41 2.14 1.98 1.87
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.34 1.12 1.35 1.20 1.38 1.51 1.52 1.48 1.02 1.12 1.22
Quick Ratio
0.49 0.36 0.53 0.54 0.70 0.86 0.89 0.86 0.54 0.63 0.68
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
237 245 -852 461 325 -642 -186 599 345 -222 181
Operating Cash Flow to CapEx
142.03% 205.61% 223.45% 265.23% 219.69% 268.76% 242.67% 352.34% 214.43% 283.10% 245.69%
Free Cash Flow to Firm to Interest Expense
3.54 3.61 -7.26 3.88 3.03 -6.10 -1.70 4.69 1.99 -1.33 0.95
Operating Cash Flow to Interest Expense
5.02 5.82 3.32 4.26 4.73 5.72 5.07 5.86 2.78 4.31 3.85
Operating Cash Flow Less CapEx to Interest Expense
1.48 2.99 1.84 2.66 2.57 3.59 2.98 4.19 1.49 2.79 2.29
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.16 1.14 1.05 0.96 0.94 0.86 0.80 0.85 0.80 0.72 0.72
Accounts Receivable Turnover
12.72 12.69 11.01 9.21 8.84 8.75 8.53 9.36 9.52 9.81 10.95
Inventory Turnover
5.45 5.04 5.22 5.54 5.96 6.19 6.45 6.84 5.84 5.18 5.31
Fixed Asset Turnover
3.44 3.17 3.09 2.96 0.00 0.00 0.00 3.27 3.08 2.76 2.78
Accounts Payable Turnover
7.12 6.32 5.93 5.48 5.25 5.30 4.92 5.09 4.87 4.43 4.51
Days Sales Outstanding (DSO)
28.69 28.75 33.15 39.63 41.31 41.70 42.78 38.98 38.32 37.21 33.32
Days Inventory Outstanding (DIO)
66.91 72.45 69.94 65.84 61.27 58.99 56.62 53.36 62.48 70.43 68.71
Days Payable Outstanding (DPO)
51.23 57.79 61.50 66.63 69.58 68.85 74.24 71.70 74.89 82.43 80.87
Cash Conversion Cycle (CCC)
44.38 43.42 41.59 38.84 33.00 31.84 25.16 20.63 25.91 25.20 21.16
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
2,053 2,006 3,260 3,113 3,064 4,095 4,724 4,558 4,673 5,304 5,540
Invested Capital Turnover
1.83 1.78 1.55 1.40 1.45 1.38 1.29 1.38 1.30 1.17 1.20
Increase / (Decrease) in Invested Capital
-19 -46 1,254 -147 -49 1,031 630 -166 115 630 237
Enterprise Value (EV)
2,853 2,926 5,443 4,643 5,265 6,739 7,716 8,372 7,530 8,873 7,532
Market Capitalization
1,440 1,389 2,950 2,411 3,224 3,897 4,555 5,532 4,746 5,559 4,266
Book Value per Share
$10.58 $7.78 $6.94 $7.97 $9.24 $11.33 $14.15 $15.61 $17.74 $18.63 $21.52
Tangible Book Value per Share
($2.79) ($5.24) ($7.45) ($5.88) ($4.27) ($10.18) ($11.83) ($9.36) ($7.98) ($11.20) ($10.53)
Total Capital
2,153 2,031 3,313 3,186 3,268 4,504 5,356 5,144 5,316 6,126 6,621
Total Debt
1,514 1,562 2,547 2,305 2,244 3,251 3,793 3,425 3,427 4,137 4,347
Total Long-Term Debt
1,361 1,344 2,439 2,134 2,215 3,223 3,773 3,345 2,546 3,420 3,715
Net Debt
1,414 1,537 2,494 2,232 2,041 2,842 3,162 2,840 2,784 3,314 3,266
Capital Expenditures (CapEx)
236 192 174 191 231 224 229 212 225 255 297
Debt-free, Cash-free Net Working Capital (DFCFNWC)
316 293 389 308 214 226 176 189 275 169 91
Debt-free Net Working Capital (DFNWC)
416 317 442 381 418 636 808 775 917 992 1,172
Net Working Capital (NWC)
264 100 334 211 388 608 787 695 37 275 540
Net Nonoperating Expense (NNE)
46 45 132 91 83 80 85 92 134 132 129
Net Nonoperating Obligations (NNO)
1,414 1,537 2,494 2,232 2,041 2,842 3,162 2,840 2,784 3,314 3,266
Total Depreciation and Amortization (D&A)
146 147 178 196 210 224 256 268 269 281 325
Debt-free, Cash-free Net Working Capital to Revenue
8.41% 8.10% 9.51% 6.93% 4.77% 4.59% 3.10% 2.95% 4.58% 2.89% 1.40%
Debt-free Net Working Capital to Revenue
11.06% 8.79% 10.82% 8.57% 9.31% 12.91% 14.23% 12.09% 15.32% 16.95% 18.07%
Net Working Capital to Revenue
7.02% 2.78% 8.16% 4.74% 8.65% 12.34% 13.87% 10.84% 0.62% 4.70% 8.33%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$2.83 $2.56 $2.44 $2.03 $1.75 $2.79 $3.25 $3.09 $3.00 $2.59 $2.71
Adjusted Weighted Average Basic Shares Outstanding
60.39M 55.05M 110.39M 110.43M 110.78M 110.06M 110.41M 110.08M 106.50M 106.79M 105.44M
Adjusted Diluted Earnings per Share
$2.81 $2.55 $2.42 $2.01 $1.74 $2.77 $3.23 $3.07 $2.98 $2.58 $2.70
Adjusted Weighted Average Diluted Shares Outstanding
60.39M 55.05M 110.39M 110.43M 110.78M 110.06M 110.41M 110.08M 106.50M 106.79M 105.44M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
60.39M 55.05M 110.39M 110.43M 110.78M 110.06M 110.41M 110.08M 106.50M 106.79M 105.44M
Normalized Net Operating Profit after Tax (NOPAT)
228 193 231 291 306 371 416 453 470 455 459
Normalized NOPAT Margin
6.05% 5.34% 5.64% 6.55% 6.81% 7.55% 7.33% 7.07% 7.84% 7.77% 7.07%
Pre Tax Income Margin
6.72% 6.42% 5.86% 6.59% 5.62% 8.27% 8.21% 7.40% 7.05% 5.94% 6.30%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
4.78 4.42 3.04 3.47 3.35 4.87 5.25 4.71 3.44 3.08 3.16
NOPAT to Interest Expense
3.26 2.92 3.42 2.65 2.57 3.69 4.04 3.39 2.65 2.44 2.20
EBIT Less CapEx to Interest Expense
1.25 1.59 1.56 1.86 1.20 2.74 3.16 3.05 2.14 1.55 1.59
NOPAT Less CapEx to Interest Expense
-0.27 0.09 1.94 1.04 0.42 1.56 1.95 1.72 1.35 0.92 0.64
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
23.05% 26.66% 15.02% 19.89% 26.23% 17.38% 17.40% 21.11% 24.20% 29.69% 29.74%
Augmented Payout Ratio
123.40% 209.72% 16.55% 23.38% 40.47% 31.02% 19.79% 34.35% 80.65% 33.06% 55.71%

Quarterly Metrics And Ratios for Silgan

This table displays calculated financial ratios and metrics derived from Silgan's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
- - - - - - - - 105,441,971.00 105,679,758.00 105,682,020.00
DEI Adjusted Shares Outstanding
- - - - - - - - 105,441,971.00 105,679,758.00 105,682,020.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - 0.60 0.72 0.99
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-7.14% -3.18% -3.22% 5.30% 11.36% 11.42% 15.11% 4.07% 6.45% 6.76% 1.57%
EBITDA Growth
-9.07% -1.53% -9.73% -10.86% 17.73% 17.25% 20.17% 6.25% 0.87% -3.48% -2.12%
EBIT Growth
-14.87% -1.49% -13.81% -25.28% 16.85% 18.10% 18.75% 7.32% -3.03% -9.84% -3.52%
NOPAT Growth
-15.71% -8.10% -8.73% -11.57% 18.01% 16.03% 12.66% -61.34% -6.52% -12.79% -8.07%
Net Income Growth
-23.41% -3.54% -9.55% -30.06% 23.20% 16.88% 13.23% -59.60% -7.24% -14.83% -7.34%
EPS Growth
-20.00% 0.00% -8.82% -30.00% 21.15% 16.90% 13.98% -57.14% -4.76% -13.25% -6.60%
Operating Cash Flow Growth
13.29% 111.61% 45.12% -13.25% -24.75% -1,159.72% 8.90% 38.26% -17.00% 12.27% 1.94%
Free Cash Flow Firm Growth
71.14% 259.23% 229.36% -2,931.56% -1,736.09% -469.19% -464.89% 62.59% 88.11% 116.03% 122.53%
Invested Capital Growth
0.67% -4.09% -3.37% 13.49% 16.22% 25.13% 24.34% 4.47% 2.94% -1.37% -1.89%
Revenue Q/Q Growth
-1.72% 4.88% 26.33% -19.14% 3.93% 4.94% 30.51% -26.89% 6.31% 5.25% 24.15%
EBITDA Q/Q Growth
-4.83% 16.27% 12.77% -26.53% 22.22% 15.80% 15.58% -35.05% 16.03% 10.81% 17.21%
EBIT Q/Q Growth
-11.42% 26.97% 17.93% -43.67% 38.53% 28.33% 18.58% -49.09% 25.18% 19.31% 26.90%
NOPAT Q/Q Growth
-13.20% 27.34% 24.26% -35.62% 15.83% 25.20% 20.66% -77.90% 180.06% 16.81% 27.18%
Net Income Q/Q Growth
-14.38% 37.95% 31.48% -54.96% 50.81% 30.87% 27.38% -83.93% 246.29% 20.18% 38.57%
EPS Q/Q Growth
-13.33% 36.54% 30.99% -54.84% 50.00% 31.75% 27.71% -83.02% 233.33% 20.00% 37.50%
Operating Cash Flow Q/Q Growth
-150.79% 103.81% 1,397.94% 198.94% -173.03% 67.60% 253.93% 279.54% -161.80% 75.70% 278.86%
Free Cash Flow Firm Q/Q Growth
368.11% 615.74% -5.64% -267.42% -44.69% -61.51% 6.74% 82.83% 54.00% 317.62% 31.11%
Invested Capital Q/Q Growth
17.08% 1.61% -1.19% -3.46% 19.90% 9.40% -1.82% -18.89% 18.14% 4.83% -2.34%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
16.97% 18.53% 16.81% 16.94% 18.44% 19.43% 16.29% 17.21% 17.02% 17.94% 16.11%
EBITDA Margin
13.63% 15.11% 13.49% 12.25% 14.41% 15.90% 14.08% 12.51% 13.65% 14.37% 13.57%
Operating Margin
8.48% 10.27% 9.59% 6.68% 8.90% 10.88% 9.89% 6.89% 8.11% 9.19% 9.39%
EBIT Margin
8.48% 10.27% 9.59% 6.68% 8.90% 10.88% 9.89% 6.89% 8.11% 9.19% 9.39%
Profit (Net Income) Margin
4.19% 5.51% 5.73% 3.19% 4.63% 5.78% 5.64% 1.24% 4.04% 4.61% 5.15%
Tax Burden Percent
75.49% 75.71% 79.78% 92.59% 77.57% 74.85% 76.20% 34.10% 74.92% 72.89% 72.69%
Interest Burden Percent
65.41% 70.86% 74.97% 51.65% 67.12% 70.93% 74.84% 52.79% 66.47% 68.81% 75.34%
Effective Tax Rate
24.51% 24.29% 20.22% 8.82% 23.76% 25.62% 24.32% 67.15% 26.51% 28.05% 27.89%
Return on Invested Capital (ROIC)
6.91% 8.00% 7.91% 7.15% 6.89% 7.97% 7.81% 2.70% 6.08% 6.40% 6.72%
ROIC Less NNEP Spread (ROIC-NNEP)
6.11% 7.17% 7.00% 5.81% 6.08% 7.12% 6.88% 2.25% 5.37% 5.68% 5.97%
Return on Net Nonoperating Assets (RNNOA)
11.98% 14.23% 13.41% 9.13% 11.99% 14.32% 12.72% 3.47% 10.36% 11.38% 11.03%
Return on Equity (ROE)
18.90% 22.23% 21.32% 16.27% 18.87% 22.29% 20.52% 6.17% 16.44% 17.78% 17.75%
Cash Return on Invested Capital (CROIC)
7.48% 11.84% 10.99% -4.45% -7.84% -15.28% -14.28% 3.33% 3.48% 7.09% 7.55%
Operating Return on Assets (OROA)
6.47% 7.69% 7.13% 4.83% 6.54% 7.84% 7.37% 4.97% 5.90% 6.46% 6.68%
Return on Assets (ROA)
3.19% 4.12% 4.26% 2.31% 3.41% 4.16% 4.20% 0.89% 2.94% 3.24% 3.66%
Return on Common Equity (ROCE)
18.90% 22.23% 21.32% 16.27% 18.87% 22.29% 20.52% 6.17% 16.44% 17.78% 17.75%
Return on Equity Simple (ROE_SIMPLE)
16.27% 15.84% 14.40% 0.00% 13.88% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
84 107 133 86 100 125 150 33 93 109 138
NOPAT Margin
6.40% 7.77% 7.65% 6.09% 6.79% 8.10% 7.48% 2.26% 5.96% 6.61% 6.77%
Net Nonoperating Expense Percent (NNEP)
0.81% 0.83% 0.91% 1.34% 0.80% 0.85% 0.93% 0.46% 0.71% 0.71% 0.76%
Return On Investment Capital (ROIC_SIMPLE)
- - - 1.40% 1.48% 1.71% 2.08% 0.50% 1.33% 1.51% 1.97%
Cost of Revenue to Revenue
83.03% 81.47% 83.19% 83.06% 81.56% 80.57% 83.71% 82.79% 82.98% 82.06% 83.89%
SG&A Expenses to Revenue
7.63% 7.80% 6.10% 8.77% 8.80% 7.92% 6.08% 8.14% 8.40% 7.72% 5.92%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
8.49% 8.26% 7.22% 10.26% 9.54% 8.55% 6.40% 10.32% 8.91% 8.75% 6.71%
Earnings before Interest and Taxes (EBIT)
112 142 167 94 131 168 199 101 127 151 192
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
179 209 235 173 211 245 283 184 213 236 277
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.71 2.34 2.73 2.79 2.62 2.61 2.03 1.88 1.76 2.06 1.48
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.88 0.77 0.97 0.95 0.91 0.94 0.72 0.66 0.62 0.73 0.55
Price to Earnings (P/E)
16.66 14.76 18.96 20.11 18.88 19.19 14.60 14.79 14.43 18.14 14.02
Dividend Yield
1.51% 1.75% 1.43% 1.46% 1.51% 1.44% 1.84% 1.98% 2.09% 1.77% 2.39%
Earnings Yield
6.00% 6.78% 5.28% 4.97% 5.30% 5.21% 6.85% 6.76% 6.93% 5.51% 7.13%
Enterprise Value to Invested Capital (EV/IC)
1.59 1.47 1.65 1.67 1.53 1.51 1.34 1.36 1.27 1.37 1.18
Enterprise Value to Revenue (EV/Rev)
1.48 1.39 1.56 1.52 1.62 1.71 1.43 1.16 1.26 1.40 1.18
Enterprise Value to EBITDA (EV/EBITDA)
10.31 9.66 11.06 11.14 11.75 12.19 10.05 8.16 9.00 10.25 8.68
Enterprise Value to EBIT (EV/EBIT)
15.15 14.20 16.54 17.23 18.23 18.82 15.50 12.60 14.00 16.25 13.84
Enterprise Value to NOPAT (EV/NOPAT)
19.64 18.73 21.40 21.72 22.98 23.90 20.05 18.04 20.23 23.78 20.68
Enterprise Value to Operating Cash Flow (EV/OCF)
15.40 10.61 10.46 12.29 16.60 30.62 24.64 10.32 13.55 14.64 12.19
Enterprise Value to Free Cash Flow (EV/FCFF)
21.38 12.12 14.72 0.00 0.00 0.00 0.00 41.71 37.08 19.16 15.45
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
2.04 2.03 1.85 2.08 2.22 2.27 2.18 1.91 2.01 2.03 1.84
Long-Term Debt to Equity
1.33 1.31 1.24 1.72 1.67 1.40 1.68 1.63 1.58 1.54 1.47
Financial Leverage
1.96 1.98 1.91 1.57 1.97 2.01 1.85 1.54 1.93 2.00 1.85
Leverage Ratio
4.19 4.10 4.06 4.18 4.10 4.12 3.99 4.22 4.11 4.13 3.98
Compound Leverage Factor
2.74 2.91 3.04 2.16 2.75 2.92 2.98 2.23 2.73 2.84 3.00
Debt to Total Capital
67.13% 67.02% 64.96% 67.52% 68.96% 69.45% 68.52% 65.65% 66.76% 67.01% 64.73%
Short-Term Debt to Total Capital
23.28% 23.85% 21.40% 11.70% 17.06% 26.63% 15.72% 9.54% 14.16% 16.33% 12.92%
Long-Term Debt to Total Capital
43.85% 43.17% 43.56% 55.82% 51.90% 42.82% 52.80% 56.11% 52.60% 50.68% 51.81%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
32.87% 32.98% 35.04% 32.48% 31.04% 30.55% 31.48% 34.35% 33.24% 32.99% 35.27%
Debt to EBITDA
4.59 4.66 4.66 5.19 5.59 5.85 5.43 4.71 5.04 5.28 5.00
Net Debt to EBITDA
4.22 4.30 4.21 4.16 5.16 5.48 5.00 3.54 4.57 4.89 4.64
Long-Term Debt to EBITDA
3.00 3.00 3.12 4.29 4.21 3.60 4.18 4.03 3.97 3.99 4.00
Debt to NOPAT
8.73 9.03 9.01 10.13 10.93 11.47 10.83 10.41 11.34 12.25 11.91
Net Debt to NOPAT
8.04 8.34 8.14 8.11 10.09 10.75 9.98 7.82 10.28 11.36 11.06
Long-Term Debt to NOPAT
5.71 5.82 6.04 8.37 8.22 7.07 8.35 8.90 8.93 9.26 9.53
Altman Z-Score
1.98 1.91 2.05 1.82 1.82 1.70 1.74 1.69 1.73 1.78 1.77
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.04 1.06 1.09 1.12 1.14 0.96 1.27 1.22 1.26 1.27 1.35
Quick Ratio
0.55 0.57 0.68 0.63 0.60 0.50 0.77 0.68 0.68 0.70 0.85
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
48 345 325 -544 -788 -1,272 -1,187 -204 -94 204 267
Operating Cash Flow to CapEx
-752.87% 37.52% 518.63% 1,414.07% -824.65% -350.01% 426.67% 1,821.83% -994.78% -313.57% 421.74%
Free Cash Flow to Firm to Interest Expense
1.25 8.34 7.77 -11.95 -18.35 -26.13 -23.74 -4.27 -2.21 4.33 5.66
Operating Cash Flow to Interest Expense
-14.17 0.51 7.48 20.54 -15.92 -4.55 6.82 27.10 -18.84 -4.12 7.35
Operating Cash Flow Less CapEx to Interest Expense
-16.06 -0.84 6.03 19.08 -17.85 -5.85 5.22 25.61 -20.73 -5.44 5.61
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.76 0.75 0.74 0.72 0.73 0.72 0.75 0.72 0.73 0.70 0.71
Accounts Receivable Turnover
6.26 5.50 4.62 9.81 6.13 5.36 4.74 10.95 6.06 4.96 4.29
Inventory Turnover
4.88 4.30 5.64 5.18 4.91 4.47 5.87 5.31 4.98 4.45 5.75
Fixed Asset Turnover
3.04 3.02 2.99 2.76 2.83 2.86 2.95 2.78 2.82 2.83 2.84
Accounts Payable Turnover
7.40 6.89 7.20 4.43 7.35 7.15 6.91 4.51 6.99 6.72 6.42
Days Sales Outstanding (DSO)
58.35 66.37 79.08 37.21 59.54 68.08 77.06 33.32 60.25 73.66 85.10
Days Inventory Outstanding (DIO)
74.81 84.80 64.72 70.43 74.26 81.65 62.20 68.71 73.36 82.03 63.53
Days Payable Outstanding (DPO)
49.31 52.97 50.67 82.43 49.69 51.05 52.79 80.87 52.20 54.32 56.84
Cash Conversion Cycle (CCC)
83.85 98.20 93.13 25.20 84.11 98.68 86.47 21.16 81.42 101.36 91.78
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
5,472 5,560 5,494 5,304 6,359 6,957 6,830 5,540 6,546 6,862 6,701
Invested Capital Turnover
1.08 1.03 1.03 1.17 1.02 0.98 1.04 1.20 1.02 0.97 0.99
Increase / (Decrease) in Invested Capital
36 -237 -192 630 887 1,397 1,337 237 187 -95 -129
Enterprise Value (EV)
8,723 8,146 9,045 8,873 9,735 10,532 9,160 7,532 8,316 9,385 7,895
Market Capitalization
5,151 4,520 5,606 5,559 5,459 5,797 4,602 4,266 4,091 4,902 3,672
Book Value per Share
$17.84 $18.11 $19.24 $18.63 $19.51 $20.77 $21.24 $21.52 $22.01 $22.51 $23.45
Tangible Book Value per Share
($7.51) ($6.92) ($6.10) ($11.20) ($11.05) ($10.93) ($10.29) ($10.53) ($9.71) ($8.88) ($7.69)
Total Capital
5,780 5,863 5,862 6,126 6,712 7,274 7,220 6,621 6,981 7,213 7,026
Total Debt
3,880 3,929 3,808 4,137 4,629 5,052 4,947 4,347 4,660 4,834 4,548
Total Long-Term Debt
2,535 2,531 2,554 3,420 3,483 3,115 3,812 3,715 3,672 3,656 3,640
Net Debt
3,572 3,626 3,440 3,314 4,276 4,735 4,558 3,266 4,225 4,482 4,223
Capital Expenditures (CapEx)
73 56 60 66 83 63 80 71 80 62 82
Debt-free, Cash-free Net Working Capital (DFCFNWC)
1,124 1,238 1,100 169 1,104 1,494 1,407 91 1,162 1,531 1,394
Debt-free Net Working Capital (DFNWC)
1,433 1,541 1,468 992 1,457 1,812 1,796 1,172 1,597 1,882 1,719
Net Working Capital (NWC)
87 143 214 275 312 -126 661 540 609 704 811
Net Nonoperating Expense (NNE)
29 31 33 41 32 36 37 15 30 33 33
Net Nonoperating Obligations (NNO)
3,572 3,626 3,440 3,314 4,276 4,735 4,558 3,266 4,225 4,482 4,223
Total Depreciation and Amortization (D&A)
68 67 68 79 81 77 84 83 87 85 85
Debt-free, Cash-free Net Working Capital to Revenue
19.09% 21.19% 19.01% 2.89% 18.39% 24.25% 21.90% 1.40% 17.66% 22.91% 20.76%
Debt-free Net Working Capital to Revenue
24.34% 26.38% 25.38% 16.95% 24.27% 29.40% 27.96% 18.07% 24.28% 28.17% 25.60%
Net Working Capital to Revenue
1.48% 2.44% 3.70% 4.70% 5.20% -2.04% 10.29% 8.33% 9.26% 10.54% 12.08%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.52 $0.71 $0.94 $0.42 $0.64 $0.83 $1.06 $0.18 $0.60 $0.72 $0.99
Adjusted Weighted Average Basic Shares Outstanding
106.65M 106.84M 106.85M 106.79M 106.92M 107.05M 106.62M 105.44M 105.59M 105.68M 105.68M
Adjusted Diluted Earnings per Share
$0.52 $0.71 $0.93 $0.42 $0.63 $0.83 $1.06 $0.18 $0.60 $0.72 $0.99
Adjusted Weighted Average Diluted Shares Outstanding
107.05M 107.02M 107.14M 106.79M 107.34M 107.25M 106.80M 105.44M 105.86M 105.68M 105.68M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
106.78M 106.78M 106.79M 106.79M 106.99M 106.99M 105.67M 105.44M 105.68M 105.68M 105.68M
Normalized Net Operating Profit after Tax (NOPAT)
93 112 149 105 108 132 155 93 99 121 150
Normalized NOPAT Margin
7.05% 8.13% 8.54% 7.44% 7.35% 8.57% 7.73% 6.35% 6.34% 7.36% 7.34%
Pre Tax Income Margin
5.55% 7.28% 7.19% 3.45% 5.97% 7.72% 7.40% 3.64% 5.39% 6.32% 7.08%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
2.89 3.43 4.00 2.07 3.04 3.44 3.97 2.12 2.98 3.21 4.06
NOPAT to Interest Expense
2.18 2.60 3.19 1.89 2.32 2.56 3.01 0.70 2.19 2.31 2.92
EBIT Less CapEx to Interest Expense
1.01 2.08 2.55 0.62 1.11 2.14 2.38 0.63 1.09 1.89 2.31
NOPAT Less CapEx to Interest Expense
0.30 1.25 1.75 0.43 0.39 1.26 1.41 -0.79 0.30 0.99 1.18
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
25.71% 26.09% 27.37% 29.69% 28.65% 27.80% 26.99% 29.74% 30.58% 32.36% 33.70%
Augmented Payout Ratio
83.38% 78.57% 30.00% 33.06% 31.60% 30.60% 48.47% 55.71% 57.34% 60.44% 40.03%

Financials Breakdown Chart

Key Financial Trends

Silgan Holdings’ latest results show a mixed picture. Revenue improved year over year in Q2 2026, but weaker margins, higher restructuring costs and a continued working-capital cash drain weighed on profitability and liquidity.

Q2 2026 revenue rose 6.8% year over year to $1.64 billion. However, gross profit declined 1.4% to $294.9 million, reducing the gross margin to approximately 18.0% from 19.4%. Operating income fell 9.8% to $151.0 million, while net income declined 14.8% to $75.8 million. Diluted EPS decreased to $0.72 from $0.83. The quarter did improve sequentially from Q1 2026, with revenue, operating income and net income increasing by roughly 5%, 19% and 20%, respectively.

Cash flow remains the main concern. Silgan generated negative operating cash flow of $194.3 million in Q2 2026, although this was an improvement from negative $221.5 million in Q2 2025. The shortfall was primarily driven by a $379.8 million use of operating working capital. Q1 2026 was particularly weak, with operating cash flow of negative $799.6 million. This contrasts with positive operating cash flow in Q3 and Q4 2025, highlighting substantial seasonal volatility.

The balance sheet has improved in some areas. Cash was $351.5 million at June 30, 2026, up 10.7% from Q2 2025, and the current ratio improved to approximately 1.27 from 0.96. Total debt declined year over year to about $4.83 billion from $5.05 billion, although debt increased sequentially in Q2 as the company issued $215.3 million of new debt. Total liabilities still represented approximately 75% of total assets, and goodwill and intangible assets together accounted for roughly $3.32 billion, or 35% of assets.

  • Revenue growth resumed: Q2 2026 revenue increased 6.8% year over year, and revenue rose 5.3% sequentially from Q1.
  • Sequential earnings recovery: Q2 operating income increased to $151.0 million from $126.6 million in Q1, while net income rose to $75.8 million from $63.0 million.
  • Lower capital spending: Q2 capital expenditures declined to $64.2 million from $72.8 million a year earlier, reducing the investment burden during a period of weak operating cash flow.
  • Improved liquidity and lower year-over-year debt: Cash increased from $317.5 million to $351.5 million, while total debt declined approximately 4.3% from Q2 2025.
  • Share count continues to trend lower: Weighted average diluted shares declined to about 105.7 million in Q2 2026 from 107.0 million in Q2 2025 and 110.5 million in Q2 2023, providing some support for per-share results.
  • Cash flow is highly seasonal: Operating cash flow was positive in Q3 and Q4 2025 but negative in both Q1 and Q2 2026. Investors should evaluate cash generation over a full year rather than relying on one quarter.
  • Dividend commitment remains visible: The quarterly dividend per share increased from $0.16 in Q3 2022 to $0.21 in Q1 2026, but recent cash flow deficits make future increases dependent on working-capital normalization.
  • Margins deteriorated year over year: Q2 gross margin fell to approximately 18.0% from 19.4%, while operating margin declined to about 9.2% from 10.9%.
  • Profitability weakened despite higher sales: Q2 net income fell 14.8% and diluted EPS declined 13.3% year over year. Q1 2026 also posted lower net income and EPS compared with Q1 2025.
  • Working capital continues to consume cash: Operating assets and liabilities used $379.8 million of cash in Q2 and $964.9 million in Q1, leaving the company reliant on financing activity to offset operating and investing outflows.

Overall, Silgan is showing improving sales and some balance-sheet progress, but the recent earnings trend is being pressured by margin compression and recurring restructuring charges. Retail investors should closely monitor whether working-capital outflows reverse in the second half of the year and whether the company can reduce debt without relying on additional borrowing.

11/16/26 08:38 PM ETAI Generated. May Contain Errors.

Silgan Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Silgan's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Silgan's net income appears to be on an upward trend, with a most recent value of $288.40 million in 2025, rising from $172.41 million in 2015. The previous period was $276.38 million in 2024. View Silgan's forecast to see where analysts expect Silgan to go next.

Silgan's total operating income in 2025 was $597.87 million, based on the following breakdown:
  • Total Gross Profit: $1.15 billion
  • Total Operating Expenses: $551.56 million

Over the last 10 years, Silgan's total revenue changed from $3.76 billion in 2015 to $6.48 billion in 2025, a change of 72.2%.

In the past 13 quarters, Silgan's cash and equivalents has ranged from $236.61 million in Q2 2023 to $435.43 million in Q1 2026, and is currently $324.99 million as of their latest financial filing in Q3 2026.

Silgan had total debt of $4.35 billion at the end of 2025, a 5.1% increase from 2024, and a 187.2% increase since 2015.

Over the last 10 years, Silgan's book value per share changed from 10.58 in 2015 to 21.52 in 2025, a change of 103.4%.



Financial statements for NYSE:SLGN last updated on 11/5/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners